Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
L Peyrin-Biroulet, WJ Sandborn… - Therapeutic …, 2021 - journals.sagepub.com
In the 1990s, tumour necrosis factor-α inhibitor therapy ushered in the biologic therapy era
for inflammatory bowel disease, leading to marked improvements in treatment options and …
for inflammatory bowel disease, leading to marked improvements in treatment options and …
[HTML][HTML] Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
L Peyrin-Biroulet, WJ Sandborn… - Therapeutic …, 2021 - ncbi.nlm.nih.gov
In the 1990s, tumour necrosis factor-α inhibitor therapy ushered in the biologic therapy era
for inflammatory bowel disease, leading to marked improvements in treatment options and …
for inflammatory bowel disease, leading to marked improvements in treatment options and …
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues.
L Peyrin-Biroulet, WJ Sandborn… - Therapeutic …, 2021 - europepmc.org
In the 1990s, tumour necrosis factor-α inhibitor therapy ushered in the biologic therapy era
for inflammatory bowel disease, leading to marked improvements in treatment options and …
for inflammatory bowel disease, leading to marked improvements in treatment options and …
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
L Peyrin-Biroulet, W Sandborn… - Therapeutic …, 2021 - hal.univ-lorraine.fr
In the 1990s, tumour necrosis factor-α inhibitor therapy ushered in the biologic therapy era
for inflammatory bowel disease, leading to marked improvements in treatment options and …
for inflammatory bowel disease, leading to marked improvements in treatment options and …
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues.
L Peyrin-Biroulet, WJ Sandborn… - Therapeutic …, 2021 - search.ebscohost.com
In the 1990s, tumour necrosis factor-α inhibitor therapy ushered in the biologic therapy era
for inflammatory bowel disease, leading to marked improvements in treatment options and …
for inflammatory bowel disease, leading to marked improvements in treatment options and …
[PDF][PDF] Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
L Peyrin-Biroulet, WJ Sandborn, R Panaccione… - 2021 - socgastro.org.br
In the 1990s, tumour necrosis factor-α inhibitor therapy ushered in the biologic therapy era
for inflammatory bowel disease, leading to marked improvements in treatment options and …
for inflammatory bowel disease, leading to marked improvements in treatment options and …
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
L Peyrin-Biroulet, WJ Sandborn… - Therapeutic …, 2021 - research.birmingham.ac.uk
In the 1990s, tumour necrosis factor-α inhibitor therapy ushered in the biologic therapy era
for inflammatory bowel disease, leading to marked improvements in treatment options and …
for inflammatory bowel disease, leading to marked improvements in treatment options and …
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
L Peyrin-Biroulet, WJ Sandborn… - Therapeutic …, 2021 - pubmed.ncbi.nlm.nih.gov
In the 1990s, tumour necrosis factor-α inhibitor therapy ushered in the biologic therapy era
for inflammatory bowel disease, leading to marked improvements in treatment options and …
for inflammatory bowel disease, leading to marked improvements in treatment options and …
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues.
L Peyrin-Biroulet, WJ Sandborn… - Therapeutic …, 2021 - europepmc.org
In the 1990s, tumour necrosis factor-α inhibitor therapy ushered in the biologic therapy era
for inflammatory bowel disease, leading to marked improvements in treatment options and …
for inflammatory bowel disease, leading to marked improvements in treatment options and …
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues.
L Peyrin-Biroulet, WJ Sandborn… - Therapeutic …, 2021 - search.ebscohost.com
In the 1990s, tumour necrosis factor-α inhibitor therapy ushered in the biologic therapy era
for inflammatory bowel disease, leading to marked improvements in treatment options and …
for inflammatory bowel disease, leading to marked improvements in treatment options and …